Communiqué from extraordinary general meeting in ChromoGenics AB (publ)
An extraordinary general meeting in ChromoGenics AB (publ) was held on 7 August 2019 at Advokatfirman Lindahl’s office on Vaksalagatan 10 in Uppsala whereby the shareholders primarily resolved on the following matters.Resolution to adopt new articles of association The extraordinary general meeting resolved to adopt new articles of association. The resolution entails that the limits for the company’s share capital shall be not be less than SEK 35,000,000 and not more than SEK 140,000,000 and that the limits for the company’s number of shares shall not be less than 175,000,000 and not